Mitchell Cairo
Pediatric Hematology-Oncology · Hawthorne, NYNPI 1669446399
Payments from drug & device makers
Across 971 payments — averaging $10,076 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$5.8M
- Merck$1M
- Servier Pharmaceuticals LLC$660K
- Regeneron$468K
- Spectrum Pharmaceuticals Inc.$387K
- Celularity Inc.$255K
- plus $1.1M from 21 others
Across 11 payments — averaging $2304.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$25K
What the payments were for
- Consulting fees$387,06535%
- Speaking & faculty fees$595,77754%
- Grants$15,0001%
- Travel & lodging$94,5729%
- Food & beverage$15,4321%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 311 | $5,839,850 |
| Merck | 21 | $1,032,579 |
| Servier Pharmaceuticals LLC | 231 | $660,252 |
| Regeneron | 5 | $467,820 |
| Spectrum Pharmaceuticals Inc. | 12 | $387,459 |
| Celularity Inc. | 8 | $255,498 |
| AbbVie | 38 | $210,715 |
| Gilead(2 entities) | 33 | $200,545 |
| Amgen | 149 | $162,591 |
| E.r. Squibb & Sons, L.L.C. | 11 | $93,065 |
| Servier Bioinnovation | 1 | $81,220 |
| Janssen Research & Development, LLC | 18 | $73,339 |
| AstraZeneca | 11 | $65,975 |
| Sanofi | 24 | $49,963 |
| Sobi, Inc | 70 | $48,644 |
| Omeros Corporation | 6 | $45,399 |
| Pfizer | 6 | $32,625 |
| Leadiant Biosciences, Inc. | 2 | $27,500 |
| Sanofi US Services Inc. | 2 | $19,500 |
| Novartis | 3 | $10,463 |
| Astrazeneca UK Limited | 1 | $6,850 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $5,150 |
| Adaptive Biotechnologies Corporation | 1 | $4,050 |
| La Jolla Pharmaceutical Company | 1 | $2,100 |
| Syndax Pharmaceuticals, Inc. | 1 | $135 |
| Kadmon Pharmaceuticals LLC | 1 | $100 |
| Mesoblast, Inc. | 1 | $99 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,783,486 in reported general payments places this provider in the 95th percentile of 196 pediatric hematology-oncology providers in New York.
See all pediatric hematology-oncology providers in New York →
Other pediatric hematology-oncology in Hawthorne
- Jennifer KrajewskiHawthorne$103K
- Lewis SilvermanNew York$33.2M
- Jamie FlerlageRochester$20.1M
- Monica BhatiaNew York$7M
- Francine BleiNew York$5.3M
- John LevineNew York$5.1M
- Jaap Jan BoelensNew York$2.5M
- Matthias KarajannisNew York$2.1M
- Nai-Kong CheungNew York$1.2M
- Julie KrystalNew Hyde Park$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.